Crescent Capital BDC (CCAP) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
Annual Meeting scheduled for May 15, 2026, will be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two Class II Directors to serve until the 2029 Annual Meeting.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Provision to transact other business that may arise during the meeting or any adjournment.
Board of directors and corporate governance
Nominees for Class II Director positions are Susan Yun Lee and Michael S. Segal, both recommended by the Board.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Crescent Capital BDC
- Directors were elected through 2029 and Ernst & Young LLP was ratified as auditor for 2026.CCAP
AGM 202615 May 2026 - Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 202614 May 2026 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 20256 May 2026 - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 20256 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025